Pharma sector doubles down on AI amid hopes of slashing costs, timelines
AstraZenecaAstraZeneca(US:AZN) Reuters·2026-01-15 16:35

Core Insights - Pharmaceutical companies are increasingly adopting artificial intelligence to enhance research and development processes, focusing on new modeling tools and automated laboratories to achieve efficiency improvements across their pipelines [1] Industry Trends - The integration of artificial intelligence in the pharmaceutical sector is seen as a strategic move to unlock potential efficiency gains, indicating a shift towards more technology-driven approaches in drug development [1]